Previous 10 | Next 10 |
Gainers: Immunomedics (NASDAQ: IMMU ) +90% . More news on: Immunomedics, Inc., Akers Biosciences, Inc., Exantas Capital Corp., Stocks on the move, , Read more ...
Pfizer ( PFE +1.9% ) and The Pfizer Foundation commit to donate $40M in medical and charitable grants to help fight the pandemic in the U.S. and around the world. More news on: Pfizer Inc., CVS Health Corporation, OPKO Health, Inc., Healthcare stocks news, Stocks on the move, Read ...
SAN DIEGO and PENNINGTON, N.J. , April 6, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral DNA‑based cancer immunotherapies, today announced that Providence Cancer Institute, a part of ...
Cellect Biotechnology (NASDAQ: APOP ) -12% after recruitment of patients halted and delay in clinical trails due to COVID-19. More news on: Cellect Biotechnology Ltd., Immunomedics, Inc., Frontline Ltd., Stocks on the move, , Read more ...
NEW YORK, NY / ACCESSWIRE / March 20, 2020 / OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, President and Chief Executive Officer of OncoSec, will present a company overview a...
SAN DIEGO and PENNINGTON, N.J. , March 17, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced the publication of positive TAVO™ monotherapy data in...
SAN DIEGO and PENNINGTON, N.J. , March 11, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced that it has received a Research and Development (R&D) Tax Inc...
Transaction Provides Immediate Cash Infusion of $30M at Premium to Market Price of $2.50/share OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announce...
OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, at its Special Meeting of Shareholders (the “Special Meeting”), based on a preliminary ...
Court Rules in Favor of OncoSec – Special Meeting of Shareholders Will Proceed as Planned Today OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today commen...
News, Short Squeeze, Breakout and More Instantly...
OncoSec Medical Incorporated Company Name:
ONCS Stock Symbol:
NASDAQ Market:
2023-06-25 06:00:00 ET 3 Tips for Investing in Penny Stocks in a Highly Volatile Market In the thrilling world of finance, penny stocks hold a unique place, providing investors with an affordable entry point and the potential for significant returns. As securities trading under $5 p...
2023-06-24 06:00:00 ET 3 Ways That Global Events Affect the Price of Penny Stocks The ever-changing global economic landscape inevitably impacts the financial markets, and penny stocks , defined as securities trading below $5 per share, are no exception. Particularly in 2023, these ...